Academies Australasia Group (AKG) Fair Value & Analysis
Consumer Defensive · AU · Market cap A$13.9M
Fair value as of: Jun 26, 2026
Analysis
Academies Australasia Group (AKG) currently trades at A$0.0740, while our model-based Fair Value estimate is A$0.1191 — implying the stock looks roughly 60.9% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Academies Australasia Group Limited provides training and education services in Australia and Singapore. The company offers bachelor's and master's degrees, vocational education and training, first aid training, and cardiopulmonary resuscitation training services. Its courses include English; high school; community services; early childhood education and care; yoga teaching and therapy; hospitality management; information technology; hairdressing, barbering, and beauty courses; leadership and management; project management; sports and fitness; travel and tourism; commercial cookery; and agriculture courses. It also holds 18 colleges that are licensed to operate as education institutions. Academies Australasia Group Limited was formerly known as Garratt's Limited. The company was incorporated in 1908 and is based in Sydney, Australia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Academies Australasia Group (AKG) undervalued?
What is the fair value of AKG?
What is the quality score of AKG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.